Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2003
10/15/2003EP1351675A2 Alpha-difluoromethylornithine (dfmo) use in the human prostate
10/15/2003EP1351672A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
10/15/2003EP1351671A1 Triphenylmethane kinesin inhibitors
10/15/2003EP1351668A1 Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles
10/15/2003EP1351648A2 Carrier vectors through an epithelium with tight junctions
10/15/2003EP1351573A1 Methods for modulating tumor growth and metastasis
10/15/2003EP1268471B1 N-heterocyclic derivatives as nos inhibitors
10/15/2003EP1079864B1 Entomopoxvirus vector for delivery and expression of heterologous dna in vertebrate cells
10/15/2003EP1054890B1 Oligodeoxyribonucleotides comprising o6-benzylguanine and their use
10/15/2003EP0946565B1 Method and device for production of lyophilized hydrochloride-1ss, 10ss-epoxy-13-dimethylamino-guaia-3(4)-en-6,12-olide
10/15/2003EP0888351B1 Pyrimido 5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production
10/15/2003EP0797575B1 Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
10/15/2003EP0758644B1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
10/15/2003EP0706568B1 Vertebrate apoptosis gene: compositions and methods
10/15/2003CN1449445A Ev-vegf nucleic acids and polypeptides and methods of use
10/15/2003CN1449412A DDS compound and process for the preparation thereof
10/15/2003CN1449408A Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
10/15/2003CN1449407A Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acidor a glutamine in the form of physiologically acceptable
10/15/2003CN1449399A Polycyclic xanthones as antibiotics
10/15/2003CN1449398A 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives
10/15/2003CN1449390A Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
10/15/2003CN1449385A Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
10/15/2003CN1449287A Fused pyrrolocarbazoles against inflammation
10/15/2003CN1449284A 维生素c组合物 Vitamin c composition
10/15/2003CN1449278A Lung surfactant compositions with dynamic swelling behaviour
10/15/2003CN1448501A Process for producing a culture of antrodia camphorata and product obtained thereby
10/15/2003CN1448409A Chi lucid ganoderma polysaccharide and prep. and use thereof
10/15/2003CN1448406A Human B lymphocyte stimulating factor mutant and constructing method and coding gene thereof
10/15/2003CN1448405A Human truncated recombination soluble TRAIL-170 protein and application for preparing tumour-curing medicine thereof
10/15/2003CN1448404A Human truncated recombination soluble TRAIL-180 protein and application for preparing tumour-curing medicine thereof
10/15/2003CN1448400A Synthetic method of 24-methylene-cholesterol-3 beta, 5 alpha, 6 beta,19-tetraalcohol
10/15/2003CN1448183A Tumour-curing specific target guiding administration system and use in preparation of tumour-curing medicine
10/15/2003CN1448164A Anticancer Chinese herbal medicine powder and its prepn
10/15/2003CN1448159A Medicine for treating cancer and preparing method thereof
10/15/2003CN1448156A Garlic and lucid ganoderma extract capsule and its prepn. method
10/15/2003CN1448147A Medicine for treating esophageal cancer and method for preparing same
10/15/2003CN1448142A Compositions comprising cytosine derivatives for the treatment of cancer
10/15/2003CN1448138A Artesunate and dihydroarteannuin medicine preparation for proofing formation of blood vessel and use thereof
10/15/2003CN1448132A Modified antineoplastic preparation based on Paclitaxel
10/15/2003CN1448128A Process for producing nanoparticles of paclitaxel and albumin
10/15/2003CN1124284C High-effective broad-spectrum antibody for inhibiting growth and metastasis of tumour
10/15/2003CN1124282C Conformationally constrained backbone cyclized somatostatin analogs
10/15/2003CN1124279C Platinum complex, its preparation and therapeutic application
10/15/2003CN1124278C Platinum complex, its preparation and therapeutic application
10/15/2003CN1124276C Rapamycin derivatives
10/15/2003CN1124260C Para retinoic acid
10/15/2003CN1124157C Pharmaceutical compositions
10/14/2003US6632962 Caspase inhibitors and uses thereof
10/14/2003US6632946 Tetracyclic analogues of camptothecins, their preparation processes, their use as medicaments and the pharmaceutical compositions containing them
10/14/2003US6632945 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain
10/14/2003US6632926 Amino acids inserted in hypervariable region; heavy chain variable domain of an antibody that binds vascular endothelial growth factor
10/14/2003US6632841 Not in the form of cyclodextrin inclusion complex; in solution with lactic acid as solubilizer
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632834 Compositions and methods for treating conditions responsive to estrogen
10/14/2003US6632822 Compounds and therapeutic methods
10/14/2003US6632820 Anticancer agents
10/14/2003US6632798 Methods for inhibiting angiogenesis
10/14/2003US6632795 Treatment of cancer
10/14/2003US6632789 Contacting with inhibitor or activator of phosphatidylinositol 3-kinase
10/14/2003US6632671 Nanoparticle encapsulation system and method
10/14/2003US6632608 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity
10/14/2003US6632176 Products and methods for brachytherapy
10/14/2003CA2385777A1 Use of anti-tnf.alpha.antibodies and another drug
10/14/2003CA2317019C Magnetically responsive composition
10/14/2003CA2286750C Application and production process of a group of anticancer compounds
10/14/2003CA2184747C Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors
10/14/2003CA2098242C Surface modified anticancer nanoparticles
10/09/2003WO2003083485A2 Protein for use in hypoxia related conditions
10/09/2003WO2003083442A2 Life sciences business systems and methods
10/09/2003WO2003083124A2 Peptide epitopes common to antigens of the same multigene family
10/09/2003WO2003083115A1 Abc transporter-associated gene abcc13
10/09/2003WO2003083113A2 Growth regulating proteins
10/09/2003WO2003083096A2 Cancer associated protein kinases and their uses
10/09/2003WO2003083083A2 Methods of using flt3-ligand in immunization protocols
10/09/2003WO2003083069A2 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb
10/09/2003WO2003083041A2 Cripto-specific antibodies
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003082920A1 Chemokines and uses thereof
10/09/2003WO2003082919A2 Ox40r binding agents
10/09/2003WO2003082918A1 Vegf peptides and their use
10/09/2003WO2003082882A1 Phospholipid derivative
10/09/2003WO2003082876A1 4-beta-1''-`(2''-(substituted benzoyl)anilino! podophyllotoxin analogues useful as anticancer agents
10/09/2003WO2003082875A2 Novel podophyllotoxin derivatives, the production thereof and the use of the same in therapeutics
10/09/2003WO2003082874A2 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
10/09/2003WO2003082873A1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives
10/09/2003WO2003082872A1 Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/09/2003WO2003082869A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003WO2003082868A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003WO2003082865A1 Medicinal antitumor composition
10/09/2003WO2003082862A1 Anti-inflammatory morpholin-acetamide derivatives
10/09/2003WO2003082859A1 Indolylmaleimide derivatives
10/09/2003WO2003082845A1 Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same
10/09/2003WO2003082842A1 Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
10/09/2003WO2003082841A1 5-substituted 1,1-dioxo-`1,2,5!thiazolidine-3-one derivatives as ptpase 1b inhibitors
10/09/2003WO2003082839A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
10/09/2003WO2003082831A1 4-anilino quinazoline derivatives as antiproliferative agents
10/09/2003WO2003082830A1 Novel fused quinazoline derivatives useful as tyrosine kinase inhibitors
10/09/2003WO2003082827A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents
10/09/2003WO2003082813A2 Improvements in pharmaceutical compositions
10/09/2003WO2003082808A1 Benzamide derivatives
1 ... 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 ... 2211